These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38615803)

  • 1. Nanoscale colocalized thermal and chemical mapping of pharmaceutical powder aerosols.
    Zhang J; Khanal D; Chan HK; Banaszak Holl MM
    Int J Pharm; 2024 May; 656():124116. PubMed ID: 38615803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.
    Khanal D; Kim J; Zhang J; Ke WR; Holl MMB; Chan HK
    Int J Pharm; 2023 Feb; 632():122563. PubMed ID: 36586629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bulk to Nanometer-Scale Infrared Spectroscopy of Pharmaceutical Dry Powder Aerosols.
    Khanal D; Zhang J; Ke WR; Banaszak Holl MM; Chan HK
    Anal Chem; 2020 Jun; 92(12):8323-8332. PubMed ID: 32406232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
    Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.
    Depasquale R; Lee SL; Saluja B; Shur J; Price R
    AAPS PharmSciTech; 2015 Jun; 16(3):589-600. PubMed ID: 25398478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
    Murnane D; Martin GP; Marriott C
    J Pharm Sci; 2009 Feb; 98(2):503-15. PubMed ID: 18506819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Electrostatic Behavior of Dry Powder-Inhaled Model Formulations.
    Jetzer MW; Morrical BD
    J Pharm Sci; 2019 Sep; 108(9):2949-2963. PubMed ID: 31004652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of an acoustically mixed pharmaceutical dry powder delivered from a novel inhaler.
    Tanaka R; Takahashi N; Nakamura Y; Hattori Y; Ashizawa K; Otsuka M
    Int J Pharm; 2018 Mar; 538(1-2):130-138. PubMed ID: 29341919
    [No Abstract]   [Full Text] [Related]  

  • 13. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ; Worth Longest P; Hindle M
    Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation.
    Muddle J; Murnane D; Parisini I; Brown M; Page C; Forbes B
    J Pharm Sci; 2015 Nov; 104(11):3861-3869. PubMed ID: 26220184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.
    Louey MD; Van Oort M; Hickey AJ
    Pharm Res; 2004 Jul; 21(7):1207-13. PubMed ID: 15290861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.
    Kubavat HA; Shur J; Ruecroft G; Hipkiss D; Price R
    Pharm Res; 2012 Apr; 29(4):994-1006. PubMed ID: 22161310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.
    Kaialy W; Martin GP; Ticehurst MD; Royall P; Mohammad MA; Murphy J; Nokhodchi A
    AAPS J; 2011 Mar; 13(1):30-43. PubMed ID: 21057906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Macro-Raman Spectroscopy on Microparticle-Based Pharmaceutical Dosage Forms.
    Wang H; Williams L; Hoe S; Lechuga-Ballesteros D; Vehring R
    Appl Spectrosc; 2015 Jul; 69(7):823-33. PubMed ID: 26037516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.